James E. Flynn - 06 Jun 2025 SCHEDULE 13G Report for Vera Therapeutics, Inc. Common Stock (VERA)

Filing Manager
James E. Flynn
Reporting Manager
Deerfield Mgmt, L.P.
Security
Vera Therapeutics, Inc. Common Stock
Symbol
VERA
Shares outstanding
63,773,657 shares
Disclosed Ownership
3,348,117 shares
Ownership
5.2%
Form type
SCHEDULE 13G
Filing time
11 Jun 2025, 17:38:07 UTC
Date of event
06 Jun 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"James E. Flynn disclosed 5.2% ownership in Vera Therapeutics, Inc. Common Stock (VERA) on 06 Jun 2025."

Quick Takeaways

  • James E. Flynn filed SCHEDULE 13G for Vera Therapeutics, Inc. Common Stock (VERA).
  • Disclosed ownership: 5.2%.
  • Date of event: 06 Jun 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 11 Jun 2025, 17:38.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deerfield Mgmt, L.P. 5.2% 3,348,117 3,348,117 0 /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
Deerfield Management Company, L.P. 5.2% 3,348,117 3,348,117 0 /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
Deerfield Partners, L.P. 5.2% 3,348,117 3,348,117 0 /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
James E. Flynn 5.2% 3,348,117 3,348,117 0 /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact

Sponsored